- Home
- FNWB vs AVTX Comparison
FNWB vs AVTX Comparison
Compare FNWB & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- AVTX
- Stock Information
- Founded
- FNWB 1923
- AVTX 2011
- Country
- FNWB United States
- AVTX United States
- Employees
- FNWB N/A
- AVTX N/A
- Industry
- FNWB Banks
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- AVTX Health Care
- Exchange
- FNWB Nasdaq
- AVTX Nasdaq
- Market Cap
- FNWB 79.5M
- AVTX 57.4M
- IPO Year
- FNWB 2015
- AVTX 2015
- Fundamental
- Price
- FNWB $8.13
- AVTX $5.09
- Analyst Decision
- FNWB Hold
- AVTX Strong Buy
- Analyst Count
- FNWB 1
- AVTX 7
- Target Price
- FNWB $12.00
- AVTX $31.00
- AVG Volume (30 Days)
- FNWB 50.2K
- AVTX 122.3K
- Earning Date
- FNWB 07-24-2025
- AVTX 08-11-2025
- Dividend Yield
- FNWB 3.44%
- AVTX N/A
- EPS Growth
- FNWB N/A
- AVTX N/A
- EPS
- FNWB N/A
- AVTX N/A
- Revenue
- FNWB $45,593,000.00
- AVTX $441,000.00
- Revenue This Year
- FNWB $38.07
- AVTX N/A
- Revenue Next Year
- FNWB $13.43
- AVTX N/A
- P/E Ratio
- FNWB N/A
- AVTX $0.74
- Revenue Growth
- FNWB N/A
- AVTX N/A
- 52 Week Low
- FNWB $6.05
- AVTX $3.39
- 52 Week High
- FNWB $12.10
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- FNWB 48.31
- AVTX 57.49
- Support Level
- FNWB $6.05
- AVTX $4.76
- Resistance Level
- FNWB $8.89
- AVTX $5.05
- Average True Range (ATR)
- FNWB 0.53
- AVTX 0.30
- MACD
- FNWB 0.10
- AVTX 0.03
- Stochastic Oscillator
- FNWB 73.24
- AVTX 84.75
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).